File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Progress in serological noninvasive diagnostic methods for non-alcoholic fatty liver disease

TitleProgress in serological noninvasive diagnostic methods for non-alcoholic fatty liver disease
Authors
KeywordsHepatic fibrosis
Hepatic steatosis
Non-alcoholic fatty liver disease (NAFLD)
Serological diagnosis
Steatohepatitis
Issue Date2021
Citation
Journal of Shanghai Jiaotong University (Medical Science), 2021, v. 41, n. 1, p. 112-117 How to Cite?
AbstractNon-alcoholic fatty liver disease (NAFLD) has become the most common chronic liver disease, along with the prevalence of obesity and metabolic syndrome. Non-alcoholic fatty liver will progress to non-alcoholic steatohepatitis (NASH), NASH-related liver fibrosis and liver cirrhosis, and even hepatocellular carcinoma. Accurate assessment and early intervention are conducive to clinical burden reduction and disease control. Although being the "golden standard" for diagnosing NAFLD, the clinical application of liver biopsy is limited due to well-known limitations and significant complications. Serological testing, as a noninvasive method, has been well-recognized among researchers and clinicians. The understanding of the pros and cons and the application ranges of various methods and indexes is helpful for clinical applications, including providing more diagnosis approaches, improving diagnosis power, relieving pain of patients, and saving medical resources. This article reviews the advances in serological noninvasive diagnostic methods for NAFLD.
Persistent Identifierhttp://hdl.handle.net/10722/342616
ISSN
2023 SCImago Journal Rankings: 0.110

 

DC FieldValueLanguage
dc.contributor.authorSang, Chao-
dc.contributor.authorLiang, Dan Dan-
dc.contributor.authorXie, Guo Xiang-
dc.contributor.authorJia, Wei-
dc.contributor.authorChen, Tian Lu-
dc.date.accessioned2024-04-17T07:05:03Z-
dc.date.available2024-04-17T07:05:03Z-
dc.date.issued2021-
dc.identifier.citationJournal of Shanghai Jiaotong University (Medical Science), 2021, v. 41, n. 1, p. 112-117-
dc.identifier.issn1674-8115-
dc.identifier.urihttp://hdl.handle.net/10722/342616-
dc.description.abstractNon-alcoholic fatty liver disease (NAFLD) has become the most common chronic liver disease, along with the prevalence of obesity and metabolic syndrome. Non-alcoholic fatty liver will progress to non-alcoholic steatohepatitis (NASH), NASH-related liver fibrosis and liver cirrhosis, and even hepatocellular carcinoma. Accurate assessment and early intervention are conducive to clinical burden reduction and disease control. Although being the "golden standard" for diagnosing NAFLD, the clinical application of liver biopsy is limited due to well-known limitations and significant complications. Serological testing, as a noninvasive method, has been well-recognized among researchers and clinicians. The understanding of the pros and cons and the application ranges of various methods and indexes is helpful for clinical applications, including providing more diagnosis approaches, improving diagnosis power, relieving pain of patients, and saving medical resources. This article reviews the advances in serological noninvasive diagnostic methods for NAFLD.-
dc.languageeng-
dc.relation.ispartofJournal of Shanghai Jiaotong University (Medical Science)-
dc.subjectHepatic fibrosis-
dc.subjectHepatic steatosis-
dc.subjectNon-alcoholic fatty liver disease (NAFLD)-
dc.subjectSerological diagnosis-
dc.subjectSteatohepatitis-
dc.titleProgress in serological noninvasive diagnostic methods for non-alcoholic fatty liver disease-
dc.typeArticle-
dc.description.naturelink_to_subscribed_fulltext-
dc.identifier.doi10.3969/j.issn.1674-8115.2021.01.021-
dc.identifier.scopuseid_2-s2.0-85101903972-
dc.identifier.volume41-
dc.identifier.issue1-
dc.identifier.spage112-
dc.identifier.epage117-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats